Researchers have come up with a new way to identify more infectious variants of viruses or bacteria that start spreading in humans - including those causing flu, COVID, whooping cough and tuberculosis ..read more

Leading clinical researcher Professor Alison Elliott has been honoured with an OBE in the King's New Year Honours for services to medicine and global health ..read more

Brazil's Bolsa Família Program (BFP), one of the world's largest conditional cash transfer programmes, was responsible for the reduction of more than half the number of tuberculosis cases and deaths among those living in extreme poverty and Indigenous groups, shows a large study coordinated by the Barcelona Institute for Global Health (ISGlobal), a center supported by "la Caixa" Foundation, the Institute of Collective Health, and the CIDACS-FIOCRUZ in Bahia, Brazil ..read more

A University of Exeter funding scheme designed to combat the global challenge of fungal antimicrobial resistance (fAMR) has announced a new call for applications ..read more

AMR is when microorganisms that cause infections, such as bacteria and viruses, change over time and no longer respond to antibiotic medicines ..read more

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic ..read more

Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, president of the International AIDS Society ..read more

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published today in Nature Microbiology ..read more

Scientists have developed an AI chatbot similar to ChatGPT to help governments devise effective policies for battling drug resistance ..read more

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), and almost halved adults' and children's risk of developing multidrug-resistant TB ..read more